These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 16320346

  • 1. Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.
    Mok CC, To CH, Mak A, Ma KM.
    Arthritis Rheum; 2005 Dec; 52(12):3997-4002. PubMed ID: 16320346
    [Abstract] [Full Text] [Related]

  • 2. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
    Mok CC, Ying SK, Ma KM, Wong CK.
    Lupus; 2013 Dec; 22(14):1470-8. PubMed ID: 24113197
    [Abstract] [Full Text] [Related]

  • 3. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harpe K.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):269-73. PubMed ID: 15059505
    [Abstract] [Full Text] [Related]

  • 4. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
    Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harper K.
    Chin Med J (Engl); 2004 Jul 17; 117(7):1029-35. PubMed ID: 15265377
    [Abstract] [Full Text] [Related]

  • 5. Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial.
    Mok CC, Ying KY, To CH, Ho LY, Yu KL, Lee HK, Ma KM.
    Ann Rheum Dis; 2011 May 17; 70(5):778-84. PubMed ID: 21187295
    [Abstract] [Full Text] [Related]

  • 6. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
    Vieira CS, Pereira FV, de Sá MF, Paulo LJ, Martins WP, Ferriani RA.
    Maturitas; 2009 Mar 20; 62(3):311-6. PubMed ID: 19193505
    [Abstract] [Full Text] [Related]

  • 7. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
    Sánchez-Guerrero J, Fragoso-Loyo HE, Neuwelt CM, Wallace DJ, Ginzler EM, Sherrer YR, McIlwain HH, Freeman PG, Aranow C, Petri MA, Deodhar AA, Blanton E, Manzi S, Kavanaugh A, Lisse JR, Ramsey-Goldman R, McKay JD, Kivitz AJ, Mease PJ, Winkler AE, Kahl LE, Lee AH, Furie RA, Strand CV, Lou L, Ahmed M, Quarles B, Schwartz KE.
    J Rheumatol; 2008 Aug 20; 35(8):1567-75. PubMed ID: 18634158
    [Abstract] [Full Text] [Related]

  • 8. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Uaratanawong S, Deesomchok U, Hiransuttikul N, Uaratanawong S.
    J Med Assoc Thai; 2004 Nov 20; 87(11):1374-9. PubMed ID: 15825716
    [Abstract] [Full Text] [Related]

  • 9. [A randomised clinical trial to study the effects of raloxifene hydrochloride on bone mineral density, biochemical markers of bone metabolism and serum lipids in postmenopausal women].
    Zheng SR, Wu YY, Zhang ZL, Yang X, Hui Y, Zhang Y, Chen SL, Den WH, Liu H, Ekangaki A, Stocks J, Harper K, Liu JL.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr 20; 38(4):226-9. PubMed ID: 12885371
    [Abstract] [Full Text] [Related]

  • 10. Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.
    McClung MR, Siris E, Cummings S, Bolognese M, Ettinger M, Moffett A, Emkey R, Day W, Somayaji V, Lee A.
    Menopause; 2006 Apr 20; 13(3):377-86. PubMed ID: 16735934
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C, Dane B, Cetin A, Erginbas M.
    Gynecol Endocrinol; 2007 Jul 20; 23(7):398-403. PubMed ID: 17701771
    [Abstract] [Full Text] [Related]

  • 12. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in postmenopausal women: a randomized clinical trial in Beijing.
    Zheng S, Wu Y, Zhang Z, Yang X, Hui Y, Zhang Y, Chen S, Deng W, Liu H, Ekangaki A, Stocks J, Harper K, Liu J.
    Chin Med J (Engl); 2003 Aug 20; 116(8):1127-33. PubMed ID: 12935394
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density changes in women with systemic lupus erythematosus.
    Boyanov M, Robeva R, Popivanov P.
    Clin Rheumatol; 2003 Oct 20; 22(4-5):318-23. PubMed ID: 14579164
    [Abstract] [Full Text] [Related]

  • 14. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.
    Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C.
    N Engl J Med; 1997 Dec 04; 337(23):1641-7. PubMed ID: 9385122
    [Abstract] [Full Text] [Related]

  • 15. The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women.
    Naylor KE, Clowes JA, Finigan J, Paggiosi MA, Peel NF, Eastell R.
    Bone; 2010 Mar 04; 46(3):592-7. PubMed ID: 19897063
    [Abstract] [Full Text] [Related]

  • 16. Bone mineral density in premenopausal women with systemic lupus erythematosus.
    Uaratanawong S, Deesomchoke U, Lertmaharit S, Uaratanawong S.
    J Rheumatol; 2003 Nov 04; 30(11):2365-8. PubMed ID: 14677178
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A follow-up study on the effects of a milk supplement on bone mineral density of postmenopausal Chinese women in Malaysia.
    Ting GP, Tan SY, Chan SP, Karuthan C, Zaitun Y, Suriah AR, Chee WS.
    J Nutr Health Aging; 2007 Nov 04; 11(1):69-73. PubMed ID: 17315084
    [Abstract] [Full Text] [Related]

  • 20. Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.
    Levy C, Harnois DM, Angulo P, Jorgensen R, Lindor KD.
    Liver Int; 2005 Feb 04; 25(1):117-21. PubMed ID: 15698408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.